Your browser doesn't support javascript.
loading
A cisplatin­incorporated liposome that targets the epidermal growth factor receptor enhances radiotherapeutic efficacy without nephrotoxicity.
Jung, Joohee; Jeong, Seong-Yun; Park, Seok Soon; Shin, Seol Hwa; Ju, Eun Jin; Choi, Jinhyang; Park, Jaesook; Lee, Jae Hee; Kim, Inki; Suh, Young-Ah; Hwang, Jung Jin; Kuroda, Shun'ichi; Lee, Jung Shin; Song, Si Yeol; Choi, Eun Kyung.
  • Jung J; Institute for Innovative Cancer Research, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138­736, Republic of Korea.
  • Jeong SY; Institute for Innovative Cancer Research, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138­736, Republic of Korea.
  • Park SS; Institute for Innovative Cancer Research, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138­736, Republic of Korea.
  • Shin SH; Institute for Innovative Cancer Research, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138­736, Republic of Korea.
  • Ju EJ; Institute for Innovative Cancer Research, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138­736, Republic of Korea.
  • Choi J; Institute for Innovative Cancer Research, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138­736, Republic of Korea.
  • Park J; Institute for Innovative Cancer Research, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138­736, Republic of Korea.
  • Lee JH; Institute for Innovative Cancer Research, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138­736, Republic of Korea.
  • Kim I; Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138­736, Republic of Korea.
  • Suh YA; Institute for Innovative Cancer Research, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138­736, Republic of Korea.
  • Hwang JJ; Institute for Innovative Cancer Research, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138­736, Republic of Korea.
  • Kuroda S; Department of Bioengineering Sciences, Graduate School of Bioagricultural Sciences Nagoya University, Aichi 464­8601, Japan.
  • Lee JS; Institute for Innovative Cancer Research, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138­736, Republic of Korea.
  • Song SY; Institute for Innovative Cancer Research, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138­736, Republic of Korea.
  • Choi EK; Institute for Innovative Cancer Research, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138­736, Republic of Korea.
Int J Oncol ; 46(3): 1268-74, 2015 Mar.
Article en En | MEDLINE | ID: mdl-25544240
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fármacos Sensibilizantes a Radiaciones / Cisplatino / Carcinoma de Pulmón de Células no Pequeñas / Terapia Molecular Dirigida / Quimioradioterapia / Receptores ErbB / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fármacos Sensibilizantes a Radiaciones / Cisplatino / Carcinoma de Pulmón de Células no Pequeñas / Terapia Molecular Dirigida / Quimioradioterapia / Receptores ErbB / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2015 Tipo del documento: Article